Bile lipid composition and haemostatic variables in a case of high density lipoprotein deficiency (Tangier disease)
暂无分享,去创建一个
C. Vergani | A. Catapano | M. Cattaneo | M. Zuin | A. C. Plancher | C. Tramaloni | S. Maccari | P. Roma
[1] H. Brewer,et al. Tangier disease : A structural defect in apolipoprotein A-I ( apoA-ITangir ) ( apolipoprotein A-1 H / dyslipoproteinemia / atherosclerosis / high density lipoproteins / cholesterol ) , 2003 .
[2] R. Lees,et al. Abnormal apoprotein A-I isoprotein composition in patients with Tangier disease. , 1982, The Journal of biological chemistry.
[3] P. Mannucci,et al. Biochemical and Metabolic Aspects of Platelet Dysfunction in Chronic Myeloproliferative Disorders , 1982, Thrombosis and Haemostasis.
[4] D. Macfarlane,et al. A relation between high-density-lipoprotein cholesterol and bile cholesterol saturation. , 1981, British medical journal.
[5] G. Noseda,et al. Familial hypo-alpha-lipoproteinemia. , 1981, Clinica chimica acta; international journal of clinical chemistry.
[6] A. Hofmann,et al. Enzymatic measurement of choline-containing phospholipids in bile. , 1981, Journal of lipid research.
[7] P. Mannucci,et al. Increased Fibrinopeptide A after Prothrombin Complex Concentrates , 1980, Thrombosis and Haemostasis.
[8] F. Nakayama,et al. Quantitative determination of bile acids in bile with reversed-phase high-performance liquid chromatography. , 1980, Journal of chromatography.
[9] H. Brewer,et al. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). , 1980, Annals of internal medicine.
[10] R. Lees,et al. Platelet function and platelet lipid composition in the dyslipoproteinemias. , 1980, Journal of lipid research.
[11] J. White,et al. Effect of cholesterol on production of thromboxane b2 by platelets in vitro. , 1980, The New England journal of medicine.
[12] J. Cazenave,et al. Effect of inhibitors of the arachidonate pathway on the release of granule contents from rabbit platelets adherent to collagen. , 1980, Laboratory investigation; a journal of technical methods and pathology.
[13] P. Walinsky,et al. Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's angina. , 1979, Prostaglandins and medicine.
[14] J. Albers,et al. Effect of human plasma apolipoproteins on the activity of purified lecithin: cholesterol acyltransferase. , 1979, Artery.
[15] M. Carey. Critical tables for calculating the cholesterol saturation of native bile. , 1978, Journal of lipid research.
[16] R. Nisman,et al. Evidence for high-density lipoprotein-free cholesterol as the primary precursor for bile-acid synthesis in man. , 1978, Surgery.
[17] D. H. Gregory,et al. Preferential utilization of free cholesterol from high-density lipoproteins for biliary cholesterol secretion in man. , 1978, Science.
[18] J. Albers. Effect of human plasma apolipoproteins on the activity of purified lecithin:cholesterol acyltransferase. , 1978, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[19] S B Hulley,et al. HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.
[20] M. Lopes-Virella,et al. Cholesterol determination in high-density lipoproteins separated by three different methods. , 1977, Clinical chemistry.
[21] G. Assmann,et al. The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins. , 1977, The Journal of clinical investigation.
[22] J. Mustard,et al. Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction. , 1976, Science.
[23] J. C. Vuletin,et al. A Light and Electron Microscopic Study , 1976 .
[24] L. Barbara,et al. Enzymatic determination of cholesterol in bile. , 1975, Clinica chimica acta; international journal of clinical chemistry.
[25] R L Jackson,et al. Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. , 1975, Biochemistry.
[26] G. Miller,et al. PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.
[27] V. Ferrans,et al. The pathology of Tangier disease. A light and electron microscopic study. , 1975, The American journal of pathology.
[28] H. Greten,et al. Lipoproteins and lipolytic plasma enzymes in a case of tangier disease. , 1974, The New England journal of medicine.
[29] G. Kostner. Studies on the cofactor requirements for lecithin:cholesterol acyltransferase. , 1974, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[30] G. Ehrlich,et al. The Metabolic Basis Of Inherited Disease. , 1973 .
[31] P. Nestel,et al. Tangier disease. Report of a case and studies of lipid metabolism. , 1972, The New England journal of medicine.
[32] P. Bale,et al. Pathology of Tangier disease , 1971, Journal of clinical pathology.
[33] K. Norum,et al. Determination of lecithin: cholesterol acyltransfer in human blood plasma. , 1971, Scandinavian journal of clinical and laboratory investigation.
[34] H. Weiss,et al. Hereditary Defect in the Platelet Release Reaction Caused by a Deficiency in the Storage Pool of Platelet Adenine Nucleotides , 1970, British journal of haematology.
[35] K. Weber,et al. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.
[36] J. Glomset,et al. The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.
[37] P. Talalay. Enzymic analysis of steroid hormones. , 1960, Methods of biochemical analysis.
[38] R. Havel,et al. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.